Pre-exposure Prophylaxis in the Perinatal Period
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
References
1.
Penazzato M, Lockman S, Colbers A, Renaud F, Calmy A, Clayden P
. Accelerating investigation of new HIV drugs in pregnancy: advancing the research agenda from theory to action. J Int AIDS Soc. 2022; 25 Suppl 2:e25912.
PMC: 9294865.
DOI: 10.1002/jia2.25912.
View
2.
Rao A, Lesko C, Mhlophe H, Rucinski K, Mcingana M, Pretorius A
. Longitudinal patterns of initiation, persistence, and cycling on preexposure prophylaxis among female sex workers and adolescent girls and young women in South Africa. AIDS. 2023; 37(6):977-986.
PMC: 10079574.
DOI: 10.1097/QAD.0000000000003500.
View
3.
White R, Dyer M, Hosseinipour M, Delany-Moretlwe S
. Including pregnant and breastfeeding people in trials of novel LAED PrEP agents: perspectives from sub-Saharan Africa community stakeholders. J Int AIDS Soc. 2023; 26 Suppl 2:e26120.
PMC: 10339002.
DOI: 10.1002/jia2.26120.
View
4.
Drake A, Wagner A, Richardson B, John-Stewart G
. Incident HIV during pregnancy and postpartum and risk of mother-to-child HIV transmission: a systematic review and meta-analysis. PLoS Med. 2014; 11(2):e1001608.
PMC: 3934828.
DOI: 10.1371/journal.pmed.1001608.
View
5.
Westreich D, Rosenberg M, Schwartz S, Swamy G
. Representation of women and pregnant women in HIV research: a limited systematic review. PLoS One. 2013; 8(8):e73398.
PMC: 3751870.
DOI: 10.1371/journal.pone.0073398.
View